Related Experiment Videos
Prolonged medical therapy for severe pediatric ulcerative colitis
D M Gold1, J J Levine, T A Weinstein
1Division of Pediatric Gastroenterology and Nutrition, Schneider Children's Hospital, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York, USA.
The American Journal of Gastroenterology
|May 1, 1995
Summary
For severe ulcerative colitis, delaying surgery beyond 14 days of medical therapy can lead to clinical remission in most patients. This approach challenges the standard 2-week surgical recommendation for refractory cases.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Internal Medicine
Background:
- The optimal timing for surgical intervention in severe ulcerative colitis (UC) is debated.
- Current guidelines often suggest surgery within 10-14 days if clinical remission is not achieved.
Purpose of the Study:
- To evaluate the clinical course and long-term outcomes of severe ulcerative colitis patients treated medically for over 14 days.
Main Methods:
- Retrospective review of hospitalized patients diagnosed with severe ulcerative colitis.
- Analysis of patients receiving medical and nutritional therapy for more than 14 days.
Main Results:
- Only 9% of patients required surgery during hospitalization.
- 91% of patients treated medically for over 14 days achieved clinical remission.
- Long-term follow-up showed 60% remained in remission, while 30% had mild to moderate colitis.
Conclusions:
- The study findings do not support immediate colectomy for refractory severe ulcerative colitis within 2 weeks of hospitalization.
- Extended medical management may be a viable option, leading to sustained remission in many patients.